skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 267  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Humans remove Journal Title: Vaccine remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The complexity and cost of vaccine manufacturing – An overview
Material Type:
Article
Add to My Research

The complexity and cost of vaccine manufacturing – An overview

Vaccine, 2017-07, Vol.35 (33), p.4064-4071 [Peer Reviewed Journal]

The Authors ;2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Jul 24, 2017 ;2017 The Authors 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.06.003 ;PMID: 28647170

Full text available

2
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic
Material Type:
Article
Add to My Research

An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic

Vaccine, 2021-01, Vol.39 (3), p.495-504 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2020.12.022 ;PMID: 33342632

Full text available

3
Optimal planning of the COVID-19 vaccine supply chain
Material Type:
Article
Add to My Research

Optimal planning of the COVID-19 vaccine supply chain

Vaccine, 2021-08, Vol.39 (37), p.5302-5312 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.07.068 ;PMID: 34373118

Full text available

4
India’s cost-effective COVID-19 vaccine development initiatives
Material Type:
Article
Add to My Research

India’s cost-effective COVID-19 vaccine development initiatives

Vaccine, 2020-11, Vol.38 (50), p.7883-7884 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2020.10.056 ;PMID: 33129610

Full text available

5
Status of research and development of vaccines for Streptococcus pyogenes
Material Type:
Article
Add to My Research

Status of research and development of vaccines for Streptococcus pyogenes

Vaccine, 2016-06, Vol.34 (26), p.2953-2958 [Peer Reviewed Journal]

The Authors ;2016 World Health Organization ;Copyright © 2016 World Health Organization. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Jun 3, 2016 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2016.03.073 ;PMID: 27032515

Full text available

6
Current and future cholera vaccines
Material Type:
Article
Add to My Research

Current and future cholera vaccines

Vaccine, 2020-02, Vol.38, p.A118-A126 [Peer Reviewed Journal]

2019 The Author(s) ;Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2019. The Author(s) ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2019.12.011 ;PMID: 31879125

Full text available

7
A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants
Material Type:
Article
Add to My Research

A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

Vaccine, 2017-10, Vol.35 (45), p.6228-6237 [Peer Reviewed Journal]

2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Oct 27, 2017 ;2017 The Authors 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.09.014 ;PMID: 28967523

Full text available

8
COVID-19 vaccine hesitancy: Lessons from Israel
Material Type:
Article
Add to My Research

COVID-19 vaccine hesitancy: Lessons from Israel

Vaccine, 2021-06, Vol.39 (29), p.3785-3786 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.05.085 ;PMID: 34090701

Full text available

9
Emerging manufacturers engagements in the COVID −19 vaccine research, development and supply
Material Type:
Article
Add to My Research

Emerging manufacturers engagements in the COVID −19 vaccine research, development and supply

Vaccine, 2020-07, Vol.38 (34), p.5418-5423 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s) ;2020 The Author(s) 2020 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2020.06.022 ;PMID: 32600908

Full text available

10
Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach
Material Type:
Article
Add to My Research

Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach

Vaccine, 2021-11, Vol.39 (47), p.6876-6882 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.10.025 ;PMID: 34688498

Full text available

11
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation
Material Type:
Article
Add to My Research

Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation

Vaccine, 2024-04, Vol.42 (12), p.2975-2982 [Peer Reviewed Journal]

2024 The Author(s) ;Copyright © 2024 The Author(s). Published by Elsevier India Pvt Ltd. All rights reserved. ;2024. The Author(s) ;2024 The Author(s) 2024 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2024.03.055 ;PMID: 38570270

Digital Resources/Online E-Resources

12
Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India
Material Type:
Article
Add to My Research

Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India

Vaccine, 2018-01, Vol.36 (2), p.264-272 [Peer Reviewed Journal]

2017 The Author(s) ;Copyright © 2017 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2017. The Author(s) ;2017 The Author(s) 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.11.031 ;PMID: 29217369

Full text available

13
Pertussis vaccination during pregnancy in Vietnam: Results of a randomized controlled trial Pertussis vaccination during pregnancy
Material Type:
Article
Add to My Research

Pertussis vaccination during pregnancy in Vietnam: Results of a randomized controlled trial Pertussis vaccination during pregnancy

Vaccine, 2016-01, Vol.34 (1), p.151-159 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 2, 2016 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2015.10.098 ;PMID: 26529073

Full text available

14
Do vaccines increase or decrease susceptibility to diseases other than those they protect against?
Material Type:
Article
Add to My Research

Do vaccines increase or decrease susceptibility to diseases other than those they protect against?

Vaccine, 2024-01, Vol.42 (3), p.426-440 [Peer Reviewed Journal]

2023 Elsevier Ltd ;Copyright © 2023 Elsevier Ltd. All rights reserved. ;2023. Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2023.12.060 ;PMID: 38158298

Full text available

15
Covid-19 vaccine trials: Ethnic diversity and immunogenicity
Material Type:
Article
Add to My Research

Covid-19 vaccine trials: Ethnic diversity and immunogenicity

Vaccine, 2021-06, Vol.39 (27), p.3541-3543 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.05.017 ;PMID: 34049734

Full text available

16
Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017
Material Type:
Article
Add to My Research

Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017

Vaccine, 2018-02, Vol.36 (7), p.921-931 [Peer Reviewed Journal]

2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. ;2017. The Authors ;2017 The Authors 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.12.029 ;PMID: 29336923

Full text available

17
The origins of the vaccine cold chain and a glimpse of the future
Material Type:
Article
Add to My Research

The origins of the vaccine cold chain and a glimpse of the future

Vaccine, 2017-04, Vol.35 (17), p.2115-2120 [Peer Reviewed Journal]

2017 ;Copyright © 2017. Published by Elsevier Ltd. ;Copyright Elsevier Limited Apr 19, 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2016.11.097 ;PMID: 28364918

Full text available

18
Marketing the COVID-19 vaccine and the implications for public health
Material Type:
Article
Add to My Research

Marketing the COVID-19 vaccine and the implications for public health

Vaccine, 2021-08, Vol.39 (34), p.4766-4768 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.07.015 ;PMID: 34281742

Full text available

19
Dynamics of G2P[4] strain evolution and rotavirus vaccination: A review of evidence for Rotarix
Material Type:
Article
Add to My Research

Dynamics of G2P[4] strain evolution and rotavirus vaccination: A review of evidence for Rotarix

Vaccine, 2020-07, Vol.38 (35), p.5591-5600 [Peer Reviewed Journal]

2020 GlaxoSmithKline Biologicals S.A. ;Copyright © 2020 GlaxoSmithKline Biologicals S.A. Published by Elsevier Ltd.. All rights reserved. ;2020. GlaxoSmithKline Biologicals S.A. ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2020.06.059 ;PMID: 32651115

Full text available

20
Public opinion on global COVID-19 vaccine procurement and distribution policies: A nationally representative survey in Aotearoa New Zealand 2022
Material Type:
Article
Add to My Research

Public opinion on global COVID-19 vaccine procurement and distribution policies: A nationally representative survey in Aotearoa New Zealand 2022

Vaccine, 2024-02, Vol.42 (6), p.1372-1382 [Peer Reviewed Journal]

2024 The Author(s) ;Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s) ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2024.01.091 ;PMID: 38326132

Full text available

Results 1 - 20 of 267  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait